SB

Scott Biller

Executive Venture Partner at GV

Greater Boston

Overview

Work Experience

OT

OMass Therapeutics

  • Board Member

    2022 - Current

G

GV

  • Executive Venture Partner

    2021

    Searching for innovative investment opportunities in biopharma.

RT

ROME Therapeutics

  • Board Member

    2021

GB

Gate Bioscience

  • Board Observer

    2021

RT

Remix Therapeutics

  • Board Member

    2020

Vividion

  • Scientific Advisory Board member

    2019 - 2024

AP

Agios Pharmaceuticals

  • Scientific Advisory Board member

    2021 - 2023

  • Strategic Advisor

    2020 - 2021

  • Chief Scientific Officer

    2010 - 2019

DT

Denali Therapeutics

  • Scientific Advisory Board member

    2015 - 2023

NI

Novartis Institutes for BioMedical Research

  • Vice President, Global Discovery Chemistry

    2003 - 2010

Education

Investments

Gate Bioscience

Series A

Total Funding: $60M

OMass Therapeutics

Series B

Total Funding: $95M

Relevant Websites